Letter to the Editor Re: Research Progress and Efficacy Evaluation of Nivolumab in the Treatment of Metastatic Renal Cancer

• Lihua Liu ^[1] ; Shenfang Liu ^[1] ; Fang Zhao ^[2] ; Xinyu Jiang ^[3] ; Xing Dong ^[4]
  1. [1] Intensive Care Medicine Department, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), 266000 Qingdao, Shandong, China
  2. [2] Pharmacy Intravenous Admixture Services, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), 266000 Qingdao, Shandong, China
  3. [3] Department of Urology Surgery, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), 266000 Qingdao, Shandong, China
  4. [4] Intensive Care Medicine Department (II), Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), 266000 Qingdao, Shandong, China

  Mostrar afiliaciones +
• Localización: Archivos españoles de urología, ISSN 0004-0614, Tomo 78, Nº. 2, 2025, págs. 263-264
• Idioma: inglés
• Enlaces
  • Texto completo